The American Cancer Society's 2013 report projected about 1.66 million new US cancer cases and put the overall cancer death rate 20 percent below its 1991 peak, with chronic myeloid leukaemia showing the fastest fall in deaths of any cancer.
Siegel, Naishadham and Jemal projected 1,660,290 new cancer cases and 580,350 cancer deaths in the United States for 2013. Over 2005 to 2009 incidence declined slightly in men (0.6 percent a year) and was stable in women, while death rates fell 1.8 percent a year in men and 1.5 percent a year in women. The overall cancer death rate had dropped 20 percent from its 1991 peak of 215.1 per 100,000 to 173.1 in 2009, with continuing declines in lung, colorectal, breast and prostate cancer. Over 2000 to 2009 the largest annual falls in death rates were for chronic myeloid leukaemia (8.4 percent, the imatinib era), stomach cancer (3.1 percent), colorectal cancer (3.0 percent) and non-Hodgkin lymphoma (3.0 percent).
The clearest population-level signature of a targeted drug: the fall in chronic myeloid leukaemia deaths after imatinib.
Shares Siegel 2023: Cancer statistics, 2023, Siegel 2024: Cancer statistics, 2024, the American Cancer Society's annual US report, Incidence versus prevalence, Mortality.
Shares Siegel 2023: Cancer statistics, 2023, Siegel 2024: Cancer statistics, 2024, the American Cancer Society's annual US report, Incidence versus prevalence, Mortality.
Shares Siegel 2023: Cancer statistics, 2023, Siegel 2024: Cancer statistics, 2024, the American Cancer Society's annual US report, Incidence versus prevalence, Mortality.
Shares Siegel 2023: Cancer statistics, 2023, Siegel 2024: Cancer statistics, 2024, the American Cancer Society's annual US report, Incidence versus prevalence, Mortality.
Shares Siegel 2023: Cancer statistics, 2023, Siegel 2024: Cancer statistics, 2024, the American Cancer Society's annual US report, Incidence versus prevalence, Mortality.
Shares Siegel 2024: Cancer statistics, 2024, the American Cancer Society's annual US report, Incidence versus prevalence, Mortality, Cancer registries and population surveillance.
Shares Siegel 2024: Cancer statistics, 2024, the American Cancer Society's annual US report, Incidence versus prevalence, Mortality, Cancer registries and population surveillance.
Shares Siegel 2024: Cancer statistics, 2024, the American Cancer Society's annual US report, Incidence versus prevalence, Mortality, Cancer registries and population surveillance.